BeGenomics.com

Moderna sues Pfizer & BioNTech over patent infringement of  Covid-19 vaccine.

www.BeGenomics.com

 SOURCE: Moderna, Inc.

BeGenomics.com

Moderna said it is suing Pfizer and its partner BioNTech for patent infringement in the development of the first Covid-19 vaccine.

www.BeGenomics.com

BeGenomics.com

They alleging that mRNA technology it developed before the pandemic was copied.

www.BeGenomics.com

BeGenomics.com

In a statement, Moderna said Pfizer/BioNTech copied two types of its intellectual property.

www.BeGenomics.com

BeGenomics.com

One involved an mRNA structure that Moderna says its scientists began developing in 2010 and were the first to validate in human trials in 2015.

www.BeGenomics.com

BeGenomics.com

The second alleged infringement involves the coding of the spike protein on the outside of the virus itself.

www.BeGenomics.com

BeGenomics.com

This groundbreaking technology was critical to the development of Moderna's own mRNA COVID-19 vaccine, Spikevax®.

www.BeGenomics.com

BeGenomics.com

Pfizer and BioNTech copied this technology, without Moderna's permission, to make Comirnaty®.

www.BeGenomics.com

BeGenomics.com

We believe that Pfizer and BioNTech unlawfully copied Moderna's inventions, and they have continued to use them without permission," said Moderna Chief Legal Officer

www.BeGenomics.com

BeGenomics.com

Moderna and Pfizer’s two-shot vaccines both use mRNA technology to help patients fight the coronavirus.

News source:
Moderna Inc

www.BeGenomics.com